Effect of Complementary and Alternative Medicine on Pain Among Inpatients
NCT ID: NCT02190240
Last Updated: 2017-01-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
4422 participants
OBSERVATIONAL
2012-01-31
2015-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Positive results from this study will assist hospitals in the integration of usual care and CAM therapy for pain reduction. Findings may also drive future research on the cost effectiveness of these therapies for pain management, as well as the impact on patient outcomes such as length of stay and use of narcotics.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Attenuation of Pain in Men and Women
NCT01220414
Role of the Endogenous Opioid System Underlying Modulation of Experimental Pain
NCT01327326
Effects of a Range of Naltrexone Doses in Combination With Smoked Marijuana
NCT00403117
Cannabis Vs Opioids Pain Management Objective Testing Comparisons
NCT03734731
Subjective Observational Study of Patients Using Transdermal Cream Medication And/Or Transdermal Patches With Or Without Oral Non-Narcotic Medications
NCT03768011
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consent to release of electronic health record for research purposes
* 18 years of age or older
* Length of stay greater than 24 hours
* Admission to Abbott Northwestern Hospital
* Length of stay greater than 24 hours
* 18 years of age or older
* Consent to release of electronic health record for research purposes
* Received CAM therapy in current hospitalization
* Pain level of 1 or greater at the pre-treatment assessment by practitioner
* English-speaking
* Integrative medicine therapy ended between 9:00 am and 4:00 pm
Exclusion Criteria
* Refuses consent
* Unable to provide consent due to competency concerns
* Has declined study participation 3 times during current hospitalization
* Has hard declined during current hospitalization
* Has been approached 6 times during current hospitalization
* Has been approached to consent earlier that day
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Center for Complementary and Integrative Health (NCCIH)
NIH
Allina Health System
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jeffery Dusek, PhD
Role: PRINCIPAL_INVESTIGATOR
Allina Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Abbott Northwestern Hospital
Minneapolis, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Dusek JA, Rivard RL, Griffin KH, Finch MD. Significant Pain Reduction in Hospitalized Patients Receiving Integrative Medicine Interventions by Clinical Population and Accounting for Pain Medication. J Altern Complement Med. 2021 Mar;27(S1):S28-S36. doi: 10.1089/acm.2021.0051.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AT006518-01
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.